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后，肿瘤干细胞可再次增殖形成肿瘤。干细胞转录因子 Oct4 及 Nanog 参与胚胎
干细胞和原始生殖细胞的自我更新，是维持细胞全能性所必须的转录因子，在








的致瘤能力，对其干细胞特性进行鉴定。其次，通过 Real-time PCR 及 Westen Blot
等方法检测其 Oct4 及 Nanog 的表达情况。随后，我们利用 siRNA 分别下调乳
腺癌干细胞中 Oct4 及 Nanog 的表达，并通过 Real-Time PCR 及 Westen Blot 等
方法检测干扰效果，探讨 Oct4 与 Nanog 在乳腺癌干细胞中的相互作用，并利用




乳腺癌干细胞的特性，下调乳腺癌干细胞中 Oct4 的表达会降低其 Nanog 的表达
水平，同样，下调乳腺癌干细胞中 Nanog 的表达也会减少其 Oct4 的表达水平，
Oct4 及 Nanog 的表达量减少均会导致乳腺癌干细胞的抗化疗药能力下降。本研
































According to the tumor stem cells hypothesis, tumors originate in the 
proliferation and differentiation of tumorstem cells. Conventional radiotherapy and 
chemotherapy can only kill the non-tumorigenic tumor cells, causing tumors to 
shrink or even disappear. However, like the normal stem cells, cancer stem cells 
have higher ability to resist radiotherapy and chemotherapy. When the treatment 
stops, tumor stem cells are able to proliferation and induce neoplasia again. 
Transcription factor Oct4 and Nanog participate in the self-renewing of embryonic 
stem cells and primordial germ cells. They are both necessary for maintaining cell 
totipotency and their expression level will reduce or disappear in the differentiated or 
mature organization. However, in the recent research, Oct4 and Nanog are found 
expressing in the tumor tissue, and the expression level is correlated with tumor 
malignancy. This is consistent with the theory that tumor stem cells exist in tumors, 
and their function in tumor stem cells has to be studied further. It has been proved 
that there are cancer stem cells in breast cancer and breast caner stem cells play a 
key role in the occurrence and development of breast cancer. We explored the 
expression and significance of Oct4 and Nanog in breast cancer stem cells by RNA 
interference in this study. 
First, we isolated breast cancer stem cells from MDAMB231 cells by 
serum-free culturing technology and detected their stem cell properties through 
measuring the cell surface markers and study the resistance to paclitaxel and 
tumorigenicity in mouse. Second, we analysed the expression of Oct4 and Nanog in 
breast cancer stem cells by Real-Time PCR and Westen Blot. After that, we down 
regulated the expression of Oct4 and Nanog respectively by siRNA and studied the 
interaction of Oct4 and Nanog in breast cancer stem cells. Finally, we determined the 
impact of resistance to chemotherapy drugs pacliaxel of breast cancer stem cells 















Through the above study, we found that some of the MDAMB231 cells that 
were able to survive in serum-free medium had higher tumorigenicity and stronger 
resistance to chemotherapy drugs than ordinary MDAMB231 cells. This cell 
subpopulation could be considered as breast cancer stem cells. When the expression 
of Oct4 in breast cancer stem cells was reduced, the Nanog expression became 
downward in response. Also, the Oct4 expression reduced when the Nanog was 
down regulated. Down-regulation of Oct4 and Nanog expression separately could 
decrease the capacity of breast cancer stem cells to resist chemotherapy drugs. Based 
on the above, We proved that the transcription factors Oct4 and Nanog play a role in 
breast cancer stem cells and are related to their chemotherapy drugs resistance. 
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瘤细胞的细胞类群[2]。转录因子 Oct4 及 Nanog 参与胚胎干细胞和原始生殖细胞
的自我更新，是维持细胞全能性所必须的转录因子[3]，也是细胞重编程的关键
转录因子[4-6]，在分化或成熟的组织中其表达水平降低或消失。然而，越来越多




































































































































1.4 转录因子 Oct4 及 Nanog 
Oct4是迄今人们发现最早也是最重要的维持胚胎干细胞多潜能性和自我更
新的关键基因，也称为 Oct3、POU5F1、OTF3 或 OTF4。Oct4 含 352 个氨基酸，
分量子为 38kD，位于人染色体 6p21.3，是 POU 家族的第五类转录因子，由
pou5f1 编码产生，具有多个转录起始位点，转录不同的 mRNA 亚型(Isoform)。
Oct4 Isoform1 是转录的主要亚型之一，具有 5 个外显子，4 个内含子，其翻译
的蛋白质含有一个保守的 DNA 结合结构域——POU 结合域，能与含八聚体基
序(octamer motif)的 DNA 结合从而调控下游靶基因的转录。目前关于 Oct4 基因
的研究主要针对 Isoform1。Oct4 表达于胚胎和生殖细胞肿瘤中，在分化细胞中
不表达。然而，近来研究发现，在非生殖系统肿瘤细胞和组织，如胰腺癌、膀
胱癌、乳腺癌等肿瘤细胞系中也检测到了 Oct4 的表达[19,21] 。 
Nanog 基因是一种在内细胞团、原始生殖细胞以及 胚胎干细胞中表达的
新转录因子[22,23]。Nanog 基因属于 ANTP 类，NK 家族基因，在人定位于 12 号





















会导致胚胎干细胞发生分化[26,27]。非生殖系统肿瘤细胞中表达 Oct4 及 Nanog
与肿瘤中存在肿瘤干细胞的说法相一致。Gibbs 等[28,29]在研究人骨肉瘤干细胞时
发现：在无血清培养基中悬浮生长的肿瘤细胞球中高表达 Nanog，但是在那些




腺癌干细胞，对其进行鉴定，并检测乳腺癌干细胞中 Oct4 及 Nanog 的表达，然
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